% Expired Patents = 85.7

CIPO Patents = 3

EPO Patents = 3

Forward Citations = 33

Loading Chart...

3 inventors (with patents filed for the assignee):

Francois Spertini (7 out of 9 patents)

Blaise Corthesy (5 out of 12 patents)

Christophe Dominique Reymond (2 out of 7 patents)

4. Alexander Kettner (0 patent)

7 patents: Sort by Forward Citations

1. 9808503 - Allergen peptide fragments and use thereof for treatment of birch pollen allergies (2017-11-07),

2. 9193773 - Allergen peptide fragments and use thereof for treatment of dust mite allergies (2015-11-24),

3. 9005627 - Contiguous overlapping peptides for treatment of ragweed pollen allergy (2015-04-14),

4. 8703144 - Allergen peptide fragments and use thereof for treatment of dust mite allergies (2014-04-22),

5. 8343503 - Contiguous overlapping peptides for treatment of birch pollen allergy (2013-01-01),

6. 8075897 - Allergen peptide fragments and use thereof (2011-12-13),

7. 7923209 - Allergen peptide fragments and use thereof (2011-04-12),

Company Overview

Anergis S.a. is a Swiss-based biopharmaceutical company focused on developing innovative allergy vaccines. Their products are designed to provide a long-lasting and efficient solution for patients suffering from allergies. Anergis uses cutting-edge technology to tailor vaccines to individual patients, making them more effective and reducing side effects. With a strong team of experts and a commitment to improving the lives of allergy sufferers, Anergis is a leader in the field of allergy immunotherapy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#4 in Epalinges

#1,340 in Switzerland

Epalinges, Switzerland

Anergis S.a.

Forward Citations = 33

3 inventors:

Francois Spertini (7 out of 9 patents)

Blaise Corthesy (5 out of 12 patents)

Christophe Dominique Reymond (2 out of 7 patents)

4. Alexander Kettner (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Anergis S.a.. Retrieved from https://idiyas.com/company/anergis-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]